What does CUSIP 67001K202 represent in this 13F holders report?

CUSIP 67001K202 is the security identifier for NVLNF - NOVELION THERAPEUTICS INC - COM NEW used to aggregate holder disclosures.

How many institutions held NVLNF - NOVELION THERAPEUTICS INC - COM NEW in Q1 2020?

No institutional holders were reported for NVLNF - NOVELION THERAPEUTICS INC - COM NEW in Q1 2020; review adjacent reporting periods for trend context.

NOVELION THERAPEUTICS INC - COM NEW (NVLNF)

CUSIP: 67001K202

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / COM NEW
Total 13F shares: 0
Share change: -7,758,418
Total reported value: $0
Number of holders: 0
Value change: -$5,454,000
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 67001K202?
CUSIP 67001K202 identifies NVLNF - NOVELION THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2019

Recent filing periods for CUSIP 67001K202:

Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018

NOVELION THERAPEUTICS INC - COM NEW (NVLNF)

Q1 2020 13F Holders as of 31 Mar 2020

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of NVLNF - NOVELION THERAPEUTICS INC - COM NEW as of Q1 2020.